Tag: JNJ

Finance

Stock Alert: Time Warner Cable Inc (NYSE:TWC), Novartis AG (ADR) (NYSE:NVS), Johnson & Johnson (NYSE:JNJ), BASF SE (ADR) (OTCMKTS:BASFY), Bayer AG (ADR) (OTCMKTS:BAYRY)

Comcast Corp.’s bid to buy Time Warner Cable Inc. (NYSE:TWC) may be the opening act for a yearlong festival of telecommunications deals that would alter Internet, phone and TV service for tens of millions of Americans. Time Warner Cable Inc (NYSE:TWC) stock performance was -1.57% in last session and finished the day at $135.97. Traded volume was 5.10million shares in the last session and the … Continue reading Stock Alert: Time Warner Cable Inc (NYSE:TWC), Novartis AG (ADR) (NYSE:NVS), Johnson & Johnson (NYSE:JNJ), BASF SE (ADR) (OTCMKTS:BASFY), Bayer AG (ADR) (OTCMKTS:BAYRY)

Chris Lewis
Finance

Stocks In Bullish Zone: Johnson & Johnson (NYSE:JNJ), QUALCOMM (NASDAQ:QCOM), PepsiCo (NYSE:PEP), Baker Hughes Incorporated (NYSE:BHI)

New Brunswick, N.J.-based Johnson & Johnson (NYSE:JNJ) is probably most famous as the parent company of multiple household products that double as household names. Listing them all would require more space than is practical, but they include Band-Aid, Listerine, Splenda, Stayfree, Lubriderm, Visine, Purell, Mylanta, Bengay, and dozens upon dozens of others. Johnson & Johnson (NYSE:JNJ)’s array of consumer goods isn’t merely wide, but dominant. … Continue reading Stocks In Bullish Zone: Johnson & Johnson (NYSE:JNJ), QUALCOMM (NASDAQ:QCOM), PepsiCo (NYSE:PEP), Baker Hughes Incorporated (NYSE:BHI)

Colin Pettis
FB Nasdaq FB Facebook
Finance

Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Johnson & Johnson (NYSE:JNJ)

A proxy advisory firm has asked shareholders of the Indian unit of Wyeth to oppose its merger deal with Pfizer Inc. (NYSE:PFE) as the share swap ratio is skewed in favour of Pfizer Inc. (NYSE:PFE). Shareholder Empowerment Services (SES) has made this suggestion ahead of the shareholder meeting this week. Pfizer Inc. (NYSE:PFE) stock performance was 0.07% in last session and finished the day at … Continue reading Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Johnson & Johnson (NYSE:JNJ)

Kristen Barton
Finance

Healthcare Most Active Stocks: Teva Pharmaceutical Industries (NYSE:TEVA), Johnson & Johnson (NYSE:JNJ), MannKind Corporation (NASDAQ:MNKD), Abbott Laboratories (NYSE:ABT)

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is one of half a dozen drugmakers that have been rolling out generics of Eli Lilly’s ($LLY) top-selling blockbuster Cymbalta. The others are going to roll past the Israeli drugmaker after it recalled more than 1 million bottles of the antidepressant. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock performance was -0.76% in last session and finished the day at … Continue reading Healthcare Most Active Stocks: Teva Pharmaceutical Industries (NYSE:TEVA), Johnson & Johnson (NYSE:JNJ), MannKind Corporation (NASDAQ:MNKD), Abbott Laboratories (NYSE:ABT)

Richard Atkins
Finance

Mega-cap Active Runners: Johnson & Johnson (NYSE:JNJ), Chevron Corporation (NYSE:CVX), Microsoft Corporation (NASDAQ:MSFT), General Electric Company (NYSE:GE)

Johnson & Johnson (NYSE:JNJ) has received a consensus recommendation of “Hold” from the seventeen ratings firms that are presently covering the company, American Banking News reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the company. Johnson & Johnson (NYSE:JNJ) stock performance was -2.44% in last session … Continue reading Mega-cap Active Runners: Johnson & Johnson (NYSE:JNJ), Chevron Corporation (NYSE:CVX), Microsoft Corporation (NASDAQ:MSFT), General Electric Company (NYSE:GE)

Jason Knox
Finance

Healthcare active runners: Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer Inc. (NYSE:PFE), MannKind Corporation (NASDAQ:MNKD)

On Monday, Johnson & Johnson (NYSE:JNJ) announced that it accepted the binding offer from The Carlyle Group (NASDAQ:CG), which was received and announced on January 16, 2014, to acquire its Ortho-Clinical Diagnostics business for approximately $4 Billion, subject to customary adjustments. Johnson & Johnson (NYSE:JNJ) stock performance was 0.16% in last session and finished the day at $98.42. Traded volume was 10.31million shares in the … Continue reading Healthcare active runners: Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer Inc. (NYSE:PFE), MannKind Corporation (NASDAQ:MNKD)

Jason Knox